One Step Further Towards Quality Expectation From Turkey : CRO Inspections Now Compulsory

Share Article

On the 9th April 2010, Turkish Ministry of Health General Directorate of Pharmaceuticals and Pharmacy has issued a declaration stating that: “in order to conduct a clinical trial in Turkey , inspections of all Contract Research Organizations (CROs) in terms of “Good Clinical Practice” by General Directorate of Pharmaceuticals and Pharmacy is mandatory.”

On the 9th April 2010, Turkish Ministry of Health General Directorate of Pharmaceuticals and Pharmacy has issued a declaration stating that:

“in order to conduct a clinical trial in Turkey , inspections of all Contract Research Organizations (CROs) in terms of “Good Clinical Practice” by General Directorate of Pharmaceuticals and Pharmacy is mandatory.”

(http://www.iegm.gov.tr/Default.aspx?sayfa=anasayfa&newsId=292)

It seems that the Turkish Ministry of Health foresees that the number of clinical trials conducted by CROs in Turky is increasing and in order to maintain the highest standard level of quality and to ensure patients’ safety, it is taking the necessary steps to improve CROs capabilities.

On looking at this progress together with the recent changes, it is obvious that Turkey is evolving to become a major player in the region in terms of clinical research activities and quality.

Clinical Trials in Turkey:

Turkey has a population of 72 Millions and also has a remarkable number of universities and specialised hospitals concentrated in the bigger cities and giving access to a large number of patients; there are 141 universities, 66 medical schools, 1191 hospitals with 200,000 beds capacity and 95,100 medical doctors are in practice of whom 46% are specialised.

The Research and Development (R/D) personnel’s number and distribution are as follows:
37% technological sciences,19% math, physics and life sciences,19% social sciences,14% medical sciences ,11% agriculture

For further information you could check http://www.klinikarastirmalar.org.tr/en/index.php

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Assem El Baghdady
AlphaBeta Pharma
+44 (0) 1372 758 344
Email >
Visit website